GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.

Guangzhou Kingmed Diagnostics Group Co., Ltd.

603882

CNE100002VW1

Healthcare Facilities & Services

End-of-day quote Shanghai S.E. Other stock markets 03:30:00 17/05/2024 am IST			5-day change	1st Jan Change
36.44 ^CNY	+4.20%		-6.76%	-41.76%

25/04	Guangzhou Kingmed Diagnostics Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
25/04	Guangzhou Kingmed Diagnostics Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Guangzhou Kingmed Diagnostics Group Co., Ltd. authorizes a Buyback Plan.

September 18, 2023

The Board of Directors of Guangzhou Kingmed Diagnostics Group Co., Ltd. has authorized a buyback plan on September 18, 2023.

Latest news about Guangzhou Kingmed Diagnostics Group Co., Ltd.

Guangzhou Kingmed Diagnostics Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04	CI
Guangzhou Kingmed Diagnostics Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	25/04	CI
Tranche Update on Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback Plan announced on January 20, 2024.	10/04	CI
Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback announced on January 20, 2024, has closed with 1,781,400 shares, representing 0.38% for CNY 99.99 million.	09/04	CI
Tranche Update on Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback Plan announced on January 20, 2024.	02/04	CI
Guangzhou Kingmed Diagnostics Group Co., Ltd. announces an Equity Buyback for CNY 100 million worth of its shares.	20/01	CI
Guangzhou Kingmed Diagnostics Group Co., Ltd. authorizes a Buyback Plan.	19/01	CI
Tranche Update on Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback Plan announced on December 19, 2023.	12/01	CI
Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback announced on December 19, 2023, has closed with 1,696,800 shares, representing 0.36% for CNY 99.99 million.	11/01	CI
Tranche Update on Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback Plan announced on December 19, 2023.	03/01	CI
Guangzhou Kingmed Diagnostics Group Co., Ltd. announces an Equity Buyback for CNY 100 million worth of its shares.	19/12	CI
Guangzhou Kingmed Diagnostics Group Co., Ltd. authorizes a Buyback Plan.	18/12	CI
Guangzhou Kingmed Diagnostics Group Co., Ltd.(SHSE:603882) dropped from SSE 180 Index	08/12	CI
Guangzhou Kingmed Diagnostics Group Co., Ltd.(SHSE:603882) dropped from Shanghai Stock Exchange 180 Value Index	08/12	CI
Tranche Update on Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback Plan announced on September 19, 2023.	15/11	CI
Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback announced on September 19, 2023, has closed with 787,600 shares, representing 0.17% for CNY 49.99 million.	14/11	CI
Guangzhou Kingmed Diagnostics Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	27/23/27	CI
Tranche Update on Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback Plan announced on September 19, 2023.	10/23/10	CI
China's Small Hospitals, Clinics Banking on AI to Bridge Barriers in Diagnosis, Treatment	19/23/19	MT
Kingmed Diagnostics to Repurchase Up to 50 Million Yuan Shares	19/23/19	MT
Guangzhou Kingmed Diagnostics Group Co., Ltd. announces an Equity Buyback for CNY 50 million worth of its shares.	19/23/19	CI
Guangzhou Kingmed Diagnostics Group Co., Ltd. authorizes a Buyback Plan.	18/23/18	CI
Guangzhou Kingmed Diagnostics Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	28/23/28	CI
Guangzhou Xinhongrui Investment Consulting Partnership (Limited Partnership), Guangzhou Xinhongyu Investment Consulting Partnership (Limited Partnership), Guangzhou Xinhongyu Investment Consulting Partnership (Limited Partnership) and Xie Jiangtao agreed to acquire 72% stake in Guangzhou Jinli Pharmaceutical Technology Co., Ltd. from Guangzhou Kingmed Diagnostics Group Co., Ltd. for CNY 220 million.	12/23/12	CI
GeneMind Biosciences Company Limited announced that it has received CNY 400 million in funding from Guangzhou Kingmed Diagnostics Group Co., Ltd., Shanghai Guoxin Investment Development Co. Ltd., Shenzhen High-Tech Investment Group Co., Ltd., Changzhou Shuangye Venture Capital, Hunan Caixin Capital Management Co., Ltd., Guochuang Zhiyuan Private Equity Fund	02/23/02	CI

Chart Guangzhou Kingmed Diagnostics Group Co., Ltd.

Duration

Period

Chart Guangzhou Kingmed Diagnostics Group Co., Ltd.

More charts

Guangzhou Kingmed Diagnostics Group Co Ltd is a company that mainly provides medical diagnosis services. The Company is also engaged in other businesses, including sales of diagnostic products, provision of physical examination and cold chain logistics services.

Sector

Healthcare Facilities & Services

Calendar

20/05/2024 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for Guangzhou Kingmed Diagnostics Group Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

36.44 CNY

Average target price

69.2 CNY

Spread / Average Target

+89.90%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical & Diagnostic Laboratories

	1st Jan change	Capi.
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-41.76%	2.25B
SONIC HEALTHCARE LIMITED	-16.99%	8.67B
RADNET, INC.	+65.23%	4.25B
DR. LAL PATHLABS LIMITED	-1.10%	2.51B
SYNLAB AG	-10.68%	2.47B
NEOGENOMICS, INC.	-8.53%	1.91B
FLEURY S.A.	-19.29%	1.56B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-39.61%	1.19B
METROPOLIS HEALTHCARE LIMITED	+9.54%	1.15B
VIJAYA DIAGNOSTIC CENTRE LIMITED	+14.87%	964M

Medical & Diagnostic Laboratories